2.25% +1.0591

크리스퍼 테라퓨틱스 (CRSP)

개요 뉴스 가격 이력 옵션 체인 Financials CRSP 왜 하락? 토론 예측

왜 CRISPR Therapeutics AG (CRSP) 주가가 하락하고 있습니까?

2024-05-08 거래 세션 동안 CRISPR Therapeutics AG(CRSP) 주식이 5.01% 하락한 것을 확인했습니다. 이는 정상적인 변동성이나 다양한 내부 및 외부 요인에 의한 것일 수 있지만, 상황을 적극적으로 모니터링하고 있으며 최대한 빨리 적시에 업데이트를 제공하도록 하겠습니다!

2023-11-13:

CRISPR Therapeutics AG Stock (CRSP) dropped by 2.16% from $53.16 to $52.01 in the trading on Monday November 13, 2023. The reason why CRSP stock down today is due to the recent lower price target by the analysts.

On Monday, Morgan Stanley analyst Terence Flynn maintained CRISPR Therapeutics with an Underweight and lowered the price target from $43 to $42.
Last Tuesday, RBC Capital analyst Luca Issi maintains CRISPR Therapeutics with a Sector Perform and lowered the price target from $55 to $50.
Needham analyst Gil Blum maintained CRISPR Therapeutics with a Buy and lowered the price target from $88 to $85.

2023-10-02:

CRISPR Therapeutics AG Stock (CRSP) dropped by 6.57% from $45.39 to 42.41 in the trading on Monday October 2, 2023. The reason why stock CRSP is down is due to upcoming FDA decisions for exa-cel. The company is awaiting FDA decisions on its exa-cel gene therapy for sickle cell disease and beta-thalassemia. These decisions are anticipated in the near future, and a few investors might be selling their CRSP shares before the decisions are made, which cause CRSP stock down.